ATH 14.3% 0.3¢ alterity therapeutics limited

Skint, this paper??: Florian Krismer et al where they found...

  1. 2,812 Posts.
    lightbulb Created with Sketch. 981
    Skint, this paper??: Florian Krismer et al where they found "Brain regions chiefly affected by MSA pathology showed progressive atrophy with annual rates of atrophy for the cerebellar cortex, cerebellar white matter, pons, and putamen of −4.24 ± 6.8%, −8.22 ± 8.8%, −4.67 ± 4.9%, and − 4.25 ± 4.9%, respectively.
    https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.29633

    I have not seen this paper earlier but it is important just for the Open study because these patients had had the disease for 4,1 years (mean) and in the Open study for over 3 years. Cerebellar white matter seems to be the best biomarker with an annual atrophy rate of 8%. It should also be measured in the open study.

    Thanks, Skint!
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
-0.001(14.3%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.4¢ 0.4¢ 0.3¢ $381 109K

Buyers (Bids)

No. Vol. Price($)
42 60011843 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 125715587 24
View Market Depth
Last trade - 14.28pm 23/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.